Search Results

Shane Wright, Michel Bouvier, et al., for their work on Conformation- and activation-based BRET sensors

🧠Do you want to share your #GPCR knowledge? Come to Dr.

June 2022 "Ottawa, Canada, May 10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs), today announced that it will be presenting important new data at both LSX World Congress and TIDES USA 2022 conference, taking place this week – May 10-12, 2022. Dr. Oliver Hartley, Orion’s Vice-President Drug Discovery, will present Orion’s novel technology for targeting undrugged peptidergic GPCRs. His presentations will describe Orion’s drug discovery platform, one of the fastest drug discovery solutions in the industry for targeting peptidergic GPCRs. Dr. Hartley will also present new data on Orion’s CCR2 antagonist, OB-004, demonstrating the ability of this powerful platform to rapidly identify best-in-class GPCR drug candidates." Read more at the source #DrGPCR #GPCR #IndustryNews

J Silvio Gutkind, a class on oncogenes and his interests for GPCRs helped shape his scientific interests

These studies shaped my future goals as an Assistant Professor in the College of Pharmacy at the University

lab has begun studying GPCR signaling pathways that operate within the primary cilium, a tiny antenna-shaped